Abstract:
BACKGROUND:Existing highly active antiretroviral therapy (HAART) effectively controls viral replication in human immunodeficiency virus type 1 (HIV-1) infected individuals but cannot completely eradicate the infection, at least in part due to the persistence of latently infected cells. One strategy that is being actively pursued to eliminate the latent aspect of HIV-1 infection involves therapies combining latency antagonists with HAART. However, discordant pharmacokinetics between these types of drugs can potentially create sites of active viral replication within certain tissues that might be impervious to HAART. RESULTS:A preliminary reverse genetic screen indicated that the proteasome might be involved in the maintenance of the latent state. This prompted testing to determine the effects of proteasome inhibitors (PIs) on latently infected cells. Experiments demonstrated that PIs effectively activated latent HIV-1 in several model systems, including primary T cell models, thereby defining PIs as a new class of HIV-1 latency antagonists. Expanding upon experiments from previous reports, it was also confirmed that PIs inhibit viral replication. Moreover, it was possible to show that PIs act as bifunctional antagonists of HIV-1. The data indicate that PIs activate latent provirus and subsequently decrease viral titers and promote the production of defective virions from activated cells. CONCLUSIONS:These results represent a proof-of-concept that bifunctional antagonists of HIV-1 can be developed and have the capacity to ensure precise tissue overlap of anti-latency and anti-replication functions, which is of significant importance in the consideration of future drug therapies aimed at viral clearance.
journal_name
Retrovirologyjournal_title
Retrovirologyauthors
Miller LK,Kobayashi Y,Chen CC,Russnak TA,Ron Y,Dougherty JPdoi
10.1186/1742-4690-10-120subject
Has Abstractpub_date
2013-10-24 00:00:00pages
120issn
1742-4690pii
1742-4690-10-120journal_volume
10pub_type
杂志文章相关文献
Retrovirology文献大全abstract:BACKGROUND:Mutations in the substrate of HIV-1 protease, especially changes in the NC/p1 cleavage site, can directly contribute to protease inhibitor (PI) resistance and also compensate for defects in viral replicative capacity (RC) due to a drug resistant protease. These NC/p1 changes are known to enhance processing o...
journal_title:Retrovirology
pub_type: 杂志文章
doi:10.1186/1742-4690-9-29
更新日期:2012-04-01 00:00:00
abstract::Few years after HTLV-1 identification and isolation in humans, STLV-1, its simian counterpart, was discovered. It then became clear that STLV-1 is present almost in all simian species. Subsequent molecular epidemiology studies demonstrated that, apart from HTLV-1 subtype A, all human subtypes have a simian homolog. As...
journal_title:Retrovirology
pub_type: 杂志文章,评审
doi:10.1186/s12977-019-0503-0
更新日期:2019-12-16 00:00:00
abstract:BACKGROUND:The reliable diagnosis of human T-cell leukemia virus type 1 (HTLV-1) infection is important, particularly as it can be vertically transmitted by breast feeding mothers to their infants. However, current diagnosis in Japan requires a confirmatory western blot (WB) test after screening/primary testing for HTL...
journal_title:Retrovirology
pub_type: 杂志文章
doi:10.1186/s12977-020-00534-0
更新日期:2020-08-24 00:00:00
abstract::The glycan supersite centered on N332 in the V3 base of the HIV-1 envelope (Env) is a target for broadly neutralizing antibodies (bnAbs) such as PGT121 and PGT128. In this study, we examined the basis of resistance of HIV-1 clade C Envs obtained from broadly cross neutralizing (BCN) plasma of an Indian donor with N332...
journal_title:Retrovirology
pub_type: 杂志文章
doi:10.1186/s12977-016-0297-2
更新日期:2016-08-30 00:00:00
abstract::HTLV-1 was the first described human retrovirus and was soon found to be associated with severe clinical diseases, including a devastating lymphoma/leukemia and other inflammatory diseases. Although HTLV-2 is not usually pathogenic, it is widely distributed among native Indian populations in Brazil, particularly in th...
journal_title:Retrovirology
pub_type: 杂志文章,评审
doi:10.1186/s12977-020-0512-z
更新日期:2020-02-14 00:00:00
abstract:BACKGROUND:HIV-1 typically develops resistance to any single antiretroviral agent. Combined anti-retroviral therapy to reduce drug-resistance development is necessary to control HIV-1 infection. Here, to assess the utility of a combination of antibody and fusion inhibitor treatments, we investigated the potency of mono...
journal_title:Retrovirology
pub_type: 杂志文章
doi:10.1186/s12977-016-0304-7
更新日期:2016-09-27 00:00:00
abstract:BACKGROUND:HIV-1 Vif interacts with the cellular core-binding factor β (CBFβ) and counteracts the protective roles of certain human APOBEC3 (A3) proteins by targeting them for proteasomal degradation. Previous studies have identified some amino acids important for Vif-CBFβ interactions, and recently a co-crystal struct...
journal_title:Retrovirology
pub_type: 杂志文章
doi:10.1186/s12977-017-0346-5
更新日期:2017-03-17 00:00:00
abstract:BACKGROUND:Eradication of HIV cannot be achieved with combination antiretroviral therapy (cART) because of the persistence of long-lived latently infected resting memory CD4(+) T cells. We previously reported that HIV latency could be established in resting CD4(+) T cells in the presence of the chemokine CCL19. To defi...
journal_title:Retrovirology
pub_type: 杂志文章
doi:10.1186/s12977-016-0284-7
更新日期:2016-07-26 00:00:00
abstract::Although antiretroviral therapy is able to suppress HIV replication in infected patients, the virus persists and rebounds when treatment is stopped. In order to find a cure that can eradicate the latent reservoir, one must be able to quantify the persisting virus. Traditionally, HIV persistence studies have used real-...
journal_title:Retrovirology
pub_type: 杂志文章,评审
doi:10.1186/s12977-018-0399-0
更新日期:2018-01-30 00:00:00
abstract:BACKGROUND:Cellular infection with human immunodeficiency virus (HIV) both in vitro and in vivo requires a member of the chemokine receptor family to act as a co-receptor for viral entry. However, it is presently unclear to what extent the interaction of HIV proteins with chemokine receptors generates intracellular sig...
journal_title:Retrovirology
pub_type: 杂志文章
doi:10.1186/1742-4690-2-23
更新日期:2005-04-04 00:00:00
abstract:BACKGROUND:HIV-1 infects a wide range of CD4+ T cells with different phenotypic properties and differing expression levels of entry coreceptors. We sought to determine the viral tropism of subtype C (C-HIV) Envelope (Env) clones for different CD4+ T cell subsets and whether tropism changes during acute to chronic disea...
journal_title:Retrovirology
pub_type: 杂志文章
doi:10.1186/s12977-020-00532-2
更新日期:2020-08-06 00:00:00
abstract:BACKGROUND:Previous studies suggest that active selection limits the number of HIV-1 variants acquired by a newly infected individual from the diverse variants circulating in the transmitting partner. We compared HIV-1 envelopes from 9 newly infected subjects and their linked transmitting partner to explore potential m...
journal_title:Retrovirology
pub_type: 杂志文章
doi:10.1186/1742-4690-10-162
更新日期:2013-12-26 00:00:00
abstract:BACKGROUND:Elderly HIV-1 infected individuals progress to AIDS more frequently and rapidly than people becoming infected at a young age. To identify possible reasons for these differences in clinical progression, we performed comprehensive phenotypic analyses of CD4+ T cells from uninfected young and elderly individual...
journal_title:Retrovirology
pub_type: 杂志文章
doi:10.1186/s12977-015-0213-1
更新日期:2015-10-09 00:00:00
abstract:BACKGROUND:Toll-like receptors (TLRs) are crucial for recognition of pathogen-associated molecular patterns by cells of the innate immune system. TLRs are present and functional in CD4⁺ T cells. Memory CD4⁺ T cells, predominantly central memory cells (TCM), constitute the main reservoir of latent HIV-1. However, how TL...
journal_title:Retrovirology
pub_type: 杂志文章
doi:10.1186/1742-4690-10-119
更新日期:2013-10-24 00:00:00
abstract::The King's College London (KCL) Infectious Diseases BioBank opened in 2007 and collects peripheral venous blood (PVB) from individuals infected with pathogens including human immunodeficiency virus (HIV). PVBs are fractionated into plasmas, lymphocytes and DNA and are then frozen. All donations are from subjects who h...
journal_title:Retrovirology
pub_type: 杂志文章
doi:10.1186/1742-4690-6-98
更新日期:2009-11-03 00:00:00
abstract::Previous studies have reported that various inbred SAM mouse strains differ markedly with regard to a variety of parameters, such as capacity for learning and memory, life spans and brain histopathology. A potential cause of differences seen in these strains may be based on the fact that some strains have a high conce...
journal_title:Retrovirology
pub_type: 杂志文章
doi:10.1186/1742-4690-5-104
更新日期:2008-11-25 00:00:00
abstract:BACKGROUND:The replication of HBV involves the production of covalently closed circular DNA (cccDNA) from the HBV genome through the repair of virion relaxed circular DNA (rcDNA) in the virion. As cccDNA is the transcription template for HBV genomes, it needs to be eliminated from hepatocytes if the eradication of chro...
journal_title:Retrovirology
pub_type: 杂志文章
doi:10.1186/s12977-016-0318-1
更新日期:2016-12-20 00:00:00
abstract::An amendment to this paper has been published and can be accessed via the original article. ...
journal_title:Retrovirology
pub_type: 杂志文章,已发布勘误
doi:10.1186/s12977-020-00531-3
更新日期:2020-07-29 00:00:00
abstract::The identification of the most appropriate marker to measure reservoir size has been a great challenge for the HIV field. Quantitative viral outgrowth assay (QVOA), the reference standard to quantify the amount of replication-competent virus, has several limitations, as it is laborious, expensive, and unable to robust...
journal_title:Retrovirology
pub_type: 杂志文章,评审
doi:10.1186/s12977-018-0396-3
更新日期:2018-02-17 00:00:00
abstract::The development of safe and effective combination antiretroviral therapies for human immunodeficiency virus (HIV) infection over the past several decades has significantly reduced HIV-associated morbidity and mortality. Additionally, antiretroviral drugs have provided an effective means of protection against HIV trans...
journal_title:Retrovirology
pub_type: 杂志文章,评审
doi:10.1186/s12977-020-00515-3
更新日期:2020-04-10 00:00:00
abstract:BACKGROUND:It has been accepted that HIV buds from the cell surface in T lymphocytes, whereas in macrophages it buds into intracellular endosomes. Recent studies, on the other hand, suggest that HIV preferentially buds from the cell surface even in monocytic cells. However, most studies are based on observations in acu...
journal_title:Retrovirology
pub_type: 杂志文章
doi:10.1186/1742-4690-6-63
更新日期:2009-07-13 00:00:00
abstract::The human immunodeficiency virus type 1 (HIV-1) Vif plays a crucial role in the viral life cycle by antagonizing a host restriction factor APOBEC3G (A3G). Vif interacts with A3G and induces its polyubiquitination and subsequent degradation via the formation of active ubiquitin ligase (E3) complex with Cullin5-ElonginB...
journal_title:Retrovirology
pub_type: 杂志文章
doi:10.1186/1742-4690-6-1
更新日期:2009-01-07 00:00:00
abstract::In order to characterize the antiviral activity of human TRIM5alpha in more detail human derived indicator cell lines over expressing wild type human TRIM5alpha were generated and challenged with HIV-1 and HIV-2 viruses pseudotyped with HIV envelope proteins in comparison to VSV-G pseudotyped particles. HIV envelope p...
journal_title:Retrovirology
pub_type: 杂志文章
doi:10.1186/1742-4690-3-79
更新日期:2006-11-06 00:00:00
abstract:BACKGROUND:Early HIV-1 infection causes massive CD4+ T cell death in the gut and translocation of bacteria into the circulation. However, the programmed cell death (PCD) pathways used by HIV-1 to kill CD4+ T cells in the gut, and the impact of microbial exposure on T cell loss, remain unclear. Understanding mucosal HIV...
journal_title:Retrovirology
pub_type: 杂志文章
doi:10.1186/1742-4690-11-14
更新日期:2014-02-04 00:00:00
abstract:BACKGROUND:Binding of the viral envelope protein (Env), and particularly of its gp120 subunit, to the cellular CD4 receptor is the first essential step of the HIV-1 entry process. The CD4 binding site (CD4bs) of gp120, and especially a recessed cavity occupied by the CD4 Phe43 residue, are known to be highly conserved ...
journal_title:Retrovirology
pub_type: 杂志文章
doi:10.1186/1742-4690-9-36
更新日期:2012-05-02 00:00:00
abstract::In the mid-1990's, researchers hypothesized, based on new viral load data, that HIV-1 causes CD4+ T-cell depletion by direct cytopathic effect. New data from non-human primate studies has raised doubts about this model of HIV-1 pathogenesis. Despite having high levels of viremia, most SIV infections are well tolerated...
journal_title:Retrovirology
pub_type: 社论
doi:10.1186/1742-4690-3-60
更新日期:2006-09-08 00:00:00
abstract:BACKGROUND:HIV infection and antiretroviral treatment are associated with changes in lipid levels, insulin resistance and risk of cardiovascular disease (CVD). We investigated these changes in the first 96 weeks of treatment with low-dose stavudine or tenofovir regimens. METHODS:This is a secondary analysis of a doubl...
journal_title:Retrovirology
pub_type: 杂志文章,随机对照试验
doi:10.1186/s12977-018-0460-z
更新日期:2018-12-14 00:00:00
abstract:BACKGROUND:HIV-1 and all retroviruses are related to retroelements of simpler organisms such as the yeast Ty elements. Recent work has suggested that the yeast retroelement Ty1 replicates via an unexpected RNA lariat intermediate in cDNA synthesis. The putative genomic RNA lariat intermediate is formed by a 2'-5' phosp...
journal_title:Retrovirology
pub_type: 杂志文章
doi:10.1186/1742-4690-2-63
更新日期:2005-10-18 00:00:00
abstract:BACKGROUND:Integration of retroviral DNA into a germ cell can result in a provirus that is transmitted vertically to the host's offspring. In humans, such endogenous retroviruses (HERVs) comprise >8% of the genome. The HERV-K(HML-2) proviruses consist of ~90 elements related to mouse mammary tumor virus, which causes b...
journal_title:Retrovirology
pub_type: 杂志文章
doi:10.1186/s12977-014-0062-3
更新日期:2014-08-12 00:00:00
abstract:BACKGROUND:While viruses have long been shown to capitalize on their limited genomic size by utilizing both strands of DNA or complementary DNA/RNA intermediates to code for viral proteins, it has been assumed that human retroviruses have all their major proteins translated only from the plus or sense strand of RNA, de...
journal_title:Retrovirology
pub_type: 杂志文章
doi:10.1186/1742-4690-3-80
更新日期:2006-11-08 00:00:00